Harber Asset Management LLC Abb Vie Inc. Transaction History

Harber Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $1.98 Million - $3 Million	-30,652 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $135,676 - $169,760	1,881 Added 6.54%	30,652 $2.71 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.81 Million - $2.18 Million	28,771 New	28,771 $2.18 Million

3,783

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $356B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Harber Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harber Asset Management LLC with notifications on news.